Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  Sire Bioscience Inc.    SIRE   CA82964J2092


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sire Bioscience : Announces the Relaunch of FusionMuscle.com; Accelerates Its Direct to Consumer (DTC) Strategy for the Onset of Cannabis Health Products (CHPs) Regulatory Playbook

11/10/2020 | 09:02am EST

(via TheNewswire)

MISSISSAUGA, Ontario -TheNewswire -November 10, 2020 - Sire Bioscience Inc. (CSE:SIRE)(CNSX:SIRE.CN)(OTC:BLLXF) (FSE:BR1B) ("Sire" or the "Company") announced the launch of the newFusionMuscle.comwebsite to offer its customers a fully optimized and seamless e-commerce experience. Easy to navigate, the user-friendly website also provides easy access to information along with a frictionless checkout.

"As a young weight training enthusiast, I grew up taking Fusion products; and this brand has staying power! Now as President, I am still part of the demographic we are focused on and the insights we have are our strength. Understanding the consumer sensibility first-hand, we are now able to overlay current consumer expectations with highly-convertible e-commerce functionality," said Blake Course, President of Fusion Nutrition Inc.

Sports nutrition company, Fusion Nutrition Inc.("FUSION") has established itself as a leading brand because of its ability to understand the current state of consumer behavior to stay relevant. The relaunch of the website is part of SIRE's DTC strategy to support the market opportunity when Cannabis Health Products ("CHPs") become legal in Canada. By scaling the distribution of its current brands, the Company will be able to add CHP offerings with already proven sales channels.

"With the relaunch of FusionMuscle.com, we are moving forward quickly to a super-responsive platform with a pipeline of feature innovation. It is part of our overarching strategy of positioning our brand distribution to leverage for the onset of Cannabis Health Products regulations by Health Canada. This is not just the beginning of our new DTC strategy but also an amazing step leap forward," said Course.

About Fusion Nutrition Inc.

Founded in 1998, FUSION is a Canadian-based, leading supplement company with national distribution. It currently hosts multiple brands, including some of the fastest-growing supplements in Canada and numerous category leaders sold in Canada's top five retailers. FUSION products are developed using the latest research available to provide maximum efficacy by supporting the human body in its own natural processes.

About Sire Bioscience Inc.

SIRE's principal business activity is to engage in the investment, production of, development of hemp, CBD, and non-CBD products. SIRE has its wholly-owned facility in Leamington, Ontario.The land parcel includes 50 acres of prime horticultural land, with a 160,000 sq. ft. facility of combined greenhouse and indoor space. SIRE's goal is to become a vertically integrated CPG life science company with its "House of Brands" offering. SIRE is headquartered in Mississauga, Ontario, and is managed by a group of successful entrepreneurs who have extensive experience in the areas of consumer packaged goods, manufacturing, logistics, and distribution.

Sire Bioscience Inc.

Forward-Looking Information Cautionary Statement

This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved".The forward-looking information contained herein include, but is not limited to, legalization of CHPs in Canada and the Company's ability to offer CHP products in future.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements.

An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading "Risks Factors" in the Company's Listing Statement dated August 22, 2019 and filed on the Company's SEDAR profile. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.

In connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given thatsuch forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by this notice.

Copyright (c) 2020 TheNewswire - All rights reserved.

Copyright (c) 2020 TheNewswire - All rights reserved., source Press Releases

2020SIRE BIOSCIENCE : Announces the Relaunch of FusionMuscle.com; Accelerates Its Di..
2020SIRE BIOSCIENCE : Announces the Appointment of New Directors of International an..
2020CSE BULLETIN : Consolidation - Sire Bioscience Inc. (SIRE)
2020SIRE BIOSCIENCE : Fusion Nutrition Inc. Files Four New NPN Applications with Hea..
2020SIRE BIOSCIENCE : Announces Binding LOI to Acquire Plant Based Protein Snack Bra..
2020SIRE BIOSCIENCE : Fusion Nutrition Inc. Announces New 1st ONES Program to Suppor..
2020SIRE BIOSCIENCE : Announces the Opening of its New Headquarters in Mississauga, ..
2020SIRE BIOSCIENCE : PURPLE-K Wins Creatine of the Year Award; Positioning Sire Bio..
2020SIRE BIOSCIENCE : (AUDIO ENHANCED) Sire Bioscience Acquires Fusion Nutrition Inc..
2020SIRE BIOSCIENCE : Acquires Fusion Nutrition Inc. to Accelerate the SIRE House of..
More news
Sales 2019 - - -
Net income 2019 -6,40 M -5,03 M -5,03 M
Net Debt 2019 3,18 M 2,50 M 2,50 M
P/E ratio 2019 -1,13x
Yield 2019 -
Capitalization 8,27 M 6,48 M 6,50 M
EV / Sales 2018 -
EV / Sales 2019 -
Nbr of Employees -
Free-Float 85,5%
Duration : Period :
Sire Bioscience Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Brian Polla President, CEO, Chief Operating Officer & Director
Domenic Crudo Chief Financial Officer & Secretary
Ben Pakulski Science Director
Jerry Habuda Independent Director
Brian Nugent Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
APHRIA INC.73.98%4 089